NRS
ACAD icon

Neville Rodie & Shaw’s Acadia Pharmaceuticals ACAD Stock Holding History

Neville Rodie & Shaw’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,000
Closed -$802K – 258
2020
Q4 		$802K Hold
15,000
– – 0.07% 134
2020
Q3 		$619K Hold
15,000
– – 0.06% 146
2020
Q2 		$727K Hold
15,000
– – 0.08% 129
2020
Q1 		$634K Hold
15,000
– – 0.08% 131
2019
Q4 		$642K Hold
15,000
– – 0.06% 154
2019
Q3 		$540K Hold
15,000
– – 0.06% 166
2019
Q2 		$401K Hold
15,000
– – 0.04% 185
2019
Q1 		$403K Hold
15,000
– – 0.04% 188
2018
Q4 		$243K Hold
15,000
– – 0.03% 209
2018
Q3 		$311K Hold
15,000
– – 0.03% 204
2018
Q2 		$229K Buy
+15,000
New +$267K 0.02% 231

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return